Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Abs. Returns |
---|---|---|---|---|
One Week | 2025-05-27 | ₹1,000.00 | ₹995.77 |
-0.42 %
|
Two Week | 2025-05-19 | ₹1,000.00 | ₹984.80 |
-1.52 %
|
1 Month | 2025-05-05 | ₹1,000.00 | ₹993.18 |
-0.68 %
|
Three Months | 2025-03-05 | ₹3,000.00 | ₹3,107.75 |
3.59 %
|
Six Months | 2024-12-05 | ₹6,000.00 | ₹5,930.49 |
-1.16 %
|
One Year | 2024-06-03 | ₹12,000.00 | ₹12,080.12 |
0.67 %
|
Since Inception | 2023-11-20 | ₹19,000.00 | ₹20,475.24 |
7.76 %
|
Company Name | Sector | Sector Type | Nav(in %) |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd. | Pharmaceuticals and Biotechnology | Equity | 15.18 |
Cipla Ltd. | Pharmaceuticals and Biotechnology | Equity | 8.3 |
Zydus Lifesciences Limited | Pharmaceuticals and Biotechnology | Equity | 6.49 |
Divi's Laboratories Ltd. | Pharmaceuticals and Biotechnology | Equity | 5.15 |
Dr. Reddy's Laboratories Ltd. | Pharmaceuticals and Biotechnology | Equity | 4.9 |
Torrent Pharmaceuticals Ltd. | Pharmaceuticals and Biotechnology | Equity | 4.79 |
Aurobindo Pharma Ltd. | Pharmaceuticals and Biotechnology | Equity | 4.04 |
Marksans Pharma Ltd | Pharmaceuticals and Biotechnology | Equity | 3.89 |
INNOVA CAPTABS LTD | Pharmaceuticals and Biotechnology | Equity | 3.27 |
Glenmark Pharmaceuticals Ltd | Pharmaceuticals and Biotechnology | Equity | 3.2 |
Ajanta Pharma Ltd. | Pharmaceuticals and Biotechnology | Equity | 3.08 |
Alkem Laboratories Ltd. | Pharmaceuticals and Biotechnology | Equity | 2.93 |
JB Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals and Biotechnology | Equity | 2.84 |
Laurus Labs Ltd. | Pharmaceuticals and Biotechnology | Equity | 2.2 |
GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals and Biotechnology | Equity | 2.06 |
Alembic Pharmaceuticals Ltd. | Pharmaceuticals and Biotechnology | Equity | 1.92 |
Jubilant Pharmova Limited | Pharmaceuticals and Biotechnology | Equity | 1.91 |
Biocon Ltd. | Pharmaceuticals and Biotechnology | Equity | 1.88 |
Emcure Pharmaceuticals Limited | Pharmaceuticals and Biotechnology | Equity | 1.86 |
Ami Organics Ltd | Pharmaceuticals and Biotechnology | Equity | 1.75 |
Max Healthcare Institute Ltd. | Healthcare Services | Equity | 4.77 |
Apollo Hospitals Enterprises Ltd. | Healthcare Services | Equity | 2.59 |
Metropolis Healthcare Ltd. | Healthcare Services | Equity | 2.11 |
Fortis Healthcare India Ltd. | Healthcare Services | Equity | 1.97 |
Krishna Institute Of Medical Sciences Ltd. | Healthcare Services | Equity | 1.87 |
GPT Healthcare Limited | Healthcare Services | Equity | 1.79 |
Narayana Hrudayalaya Ltd. | Healthcare Services | Equity | 1.5 |
Triparty Repo | Money Market | Other | 1.92 |
Net Current Assets/(Liabilities) | Unknown | Other | - |
India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.
Lock-in times for various investment types
Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.
There are two different types of residual maturity.
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Axis Innovation Fund - Regular Plan - Growth |
9.98%
|
27.76%
|
14.42%
|
Canara Robeco Consumer Trends Fund - Regular Plan - Growth |
9.95%
|
34.58%
|
16.44%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
NIPPON INDIA QUANT FUND - GROWTH |
9.90%
|
39.46%
|
12.09%
|
BARODA BNP PARIBAS INDIA CONSUMPTION FUND - REGULAR PLAN - GROWTH |
9.90%
|
31.87%
|
18.46%
|
Aditya Birla Sun Life India Reforms Fund - Growth-Regular Plan |
9.88%
|
18.78%
|
8.95%
|
Bajaj Finserv Banking and PSU Fund - Regular Plan - Growth |
9.60%
|
6.82%
|
9.12%
|
LIC MF Banking and PSU Fund - Regular Plan - Growth |
9.52%
|
11.08%
|
7.19%
|
NIPPON INDIA QUANT FUND - INSTITUTIONAL PLAN - GROWTH |
9.51%
|
2.81%
|
3.05%
|
Mirae Asset Banking and PSU Fund - Regular Plan |
9.47%
|
11.15%
|
5.56%
|
Scheme Name | 1Y Return | 3Y Return | SI Return |
---|---|---|---|
Kotak Equity Hybrid Fund - Regular Plan - Growth |
9.84%
|
26.88%
|
12.35%
|
Kotak Corporate Bond Fund - Regular Plan - Standard Growth |
9.84%
|
11.85%
|
7.88%
|
Kotak Debt Hybrid Fund - Regular Plan - Growth |
9.81%
|
18.56%
|
8.59%
|
Kotak Bond Fund - Regular Plan - Growth |
9.80%
|
11.81%
|
8.30%
|
KOTAK NIFTY SDL PLUS AAA PSU BOND JUL 2028 60:40 INDEX FUND - Regular Plan - Growth |
9.79%
|
11.04%
|
8.27%
|
Kotak Banking and PSU Debt Fund - Regular Plan - Growth |
9.59%
|
11.72%
|
7.24%
|
Kotak Global Innovation Fund of Fund - Regular Plan - Growth |
9.55%
|
26.03%
|
1.22%
|
Kotak Nifty Commodities Index Fund Regular Plan - Growth |
9.54%
|
4.66%
|
60.82%
|
Kotak Floating Rate Fund - Regular Plan - Growth |
9.40%
|
11.74%
|
7.01%
|
Kotak Bond Fund - Regular Plan - Growth |
9.33%
|
11.17%
|
7.43%
|
Interested in exploring more about JezzMoney Mutual Fund Distributors Software? Submit the form, and we will respond quickly.